Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Insights from Prof. Timothy Baily on new Real-world evidence in DELIVER G study and the implications of adding Toujeo® to people with T2D inadequately controlled on GLP-RAs.
MAT-BH-2100740/V1/October 2021